The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study
Abstract
BACKGROUND: Large transfusion requirements, i.e., excessive blood loss, during orthotopic liver transplantation (OLT) are correlated with increased morbidity and mortality. Recombinant factor VIIa (rF-VIIa) has been shown to improve hemostasis in a variety of conditions, but has never been studied in liver transplantation. METHODS: We performed a single-center, open-label, pilot study in adult patients undergoing OLT for cirrhosis Child-Pugh B or C, to assess efficacy and safety of rFVIIa. rFVIIa (80 microg/kg) was administered at the start of the operation, to be repeated according to predefined criteria. Packed red blood cells (RBC), fresh-frozen plasma, and platelet concentrates were administered according to predefined criteria. Perioperative transfusion requirements in study patients were compared with matched controls. RESULTS: Six patients were enrolled in the study. All received a single dose of rFVIIa. Transfusion requirements (given as median, with range in parentheses) were lower in the study group than in matched controls: 1.5 (0-5) vs. 7 (2-18) units of allogeneic RBC (P=0.006), 0 (0-2) vs. 3.5 (0-23) units of autologous RBC (P=0.043), total amount of RBC 3 (0-5) vs. 9 (4-40) units (P=0.002). Transfused fresh-frozen plasma was 1 (0-7) vs. 8 (2-35) units (P=0.011). Blood loss was 3.5 L (1.4-5.3) vs. 9.8 L (3.7-35.0) (P=0.004). One study patient developed a hepatic artery thrombosis at day 1 postoperatively. CONCLUSIONS: A single dose of 80 microg/kg rFVIIa significantly reduced transfusion requirements during OLT. Further study is needed to establish the optimally effective and safe dose of rFVIIa in orthotopic liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Cited by
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
Lisman, T., & Porte, R. J. (2010) · Blood · doi:10.1182/blood-2010-02-261891 · Cited by 667
Self-citationPrevention and Treatment of Major Blood Loss
Mannucci, P. M., & Levi, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067742 · Cited by 494
Treating coagulopathy in trauma patients
Armand, R., & Hess, J. R. (2003) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(03)00022-1 · Cited by 302
Factor VIIa for Correction of Traumatic Coagulopathy
Dutton, R. P., McCunn, M., Hyder, M., D’Angelo, M., O’Connor, J., Hess, J. R., & Scalea, T. M. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000140646.66852.ab · Cited by 291
The use of recombinant factor VIIa in the treatment of bleeding disorders
Roberts, H. R., Monroe, D. M., & White, G. C. (2004) · Blood · doi:10.1182/blood-2004-06-2223 · Cited by 275
Metadata
- Authors
- Hendriks, H. G. D., Meijer, K., de Wolf, J. T. M., Klompmaker, I. J., Porte, R. J., de Kam, P. J., Hagenaars, A. J. M., Melsen, T., Slooff, M. J. H., & van der Meer, J.
- Venue
- Transplantation
- Published
- 2001-02
- Volume
- 71
- Issue
- 3
- Pages
- 402-405
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2074228619
- Cited by
- 243
- References
- 1
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study. https://app.cochat.ai/papers/10.1097/00007890-200102150-00011
- The paper
- Hendriks, H. G. D., Meijer, K., de Wolf, J. T. M., Klompmaker, I. J., Porte, R. J., de Kam, P. J., Hagenaars, A. J. M., Melsen, T., Slooff, M. J. H., & van der Meer, J. (2001). REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study. Transplantation. https://doi.org/10.1097/00007890-200102150-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.